Success Story: EB1B Approved Without RFE! Our Expert Team Helped an Organic and Medicinal Chemistry Researcher Secure Success
Client’s Testimonial:
"Thank you so much for your kind reply and the support all along. I am very pleased to work with you and the quality service you provided.”
On February 17th, 2026, we received another EB1B (Outstanding Professor/Researcher) approval for an Assistant Professor in the Field of Organic and Medicinal Chemistry (Approval Notice).
General Field: Organic and Medicinal Chemistry
Position at the Time of Case Filing: Assistant Professor
Country of Origin: India
State of Residence at the Time of Filing: New York
Approval Notice Date: February 17th, 2026
Processing Time: 13 months, 7 days
Case Summary:
North America Immigration Law Group (Chen Immigration Law Associates) is pleased to share an I-140 EB-1B (Outstanding Professor or Researcher) approval for the client, an organic and medicinal chemistry researcher whose work strengthens how complex molecules are designed, synthesized, and evaluated for biomedical use. At the time of filing, the client was employed in the United States as an assistant professor role aligned with organic and medicinal chemistry research and teaching.
With a Ph.D. in organic chemistry, the client has developed specialized expertise spanning organic synthesis, organometallic chemistry, and medicinal chemistry, with a consistent focus on building molecules with defined biological properties and developing synthetic routes that enable drug discovery. In privacy-protective terms, the petition emphasized contributions that help researchers understand how small molecules interact with biological systems and how targeted chemical design can be translated into treatment-relevant strategies, including work that clarified key chaperone proteins as important targets for therapeutic development.
For EB-1B, strong metrics help, but they are not automatically decisive. The key is showing that the field repeatedly treats the work as worth publishing, worth citing, and worth trusting. To demonstrate that pattern, the petition documented peer-reviewed authorship, independent citation uptake, and professional trust signals:
- 16 peer-reviewed published journal articles (9 first-authored or co-first-authored) and 1 accepted paper
- 273 citations to the published body of work, reflecting independent reliance by researchers building on the client’s findings
- At least 19 completed peer reviews, demonstrating trust in the client’s judgment as an evaluator of others’ work
- Research support connected to major U.S. funding sources, including the National Institutes of Health and the National Science Foundation
These indicators were not presented as self-explanatory. The filing explained why they matter in context: consistent publication in highly selective venues indicates repeated success under rigorous expert review, citations are most persuasive when framed as evidence of independent reliance rather than a popularity score, and peer-review invitations are meaningful because journals typically rely on reviewers they view as technically authoritative and reliable. Funding support served as an additional objective anchor that the research direction has been competitively evaluated and aligns with high-priority scientific and health objectives.
The petition included six letters of recommendation, including multiple independent advisory perspectives from experts familiar with the client’s work through reading and relying on the published research. These letters connected the client’s chemistry contributions to broader significance in synthesis-driven drug discovery and confirmed why the client’s work has become useful to other specialists in the field.
“There is thus no doubt that he shall continue to produce additional valuable research, both driving progress in the field and bringing immense benefits to national and international concerns.”
USCIS approved the EB-1B petition without RFE, reflecting a record that presented the client as an outstanding researcher whose work has earned repeated peer validation through selective publication, independent citation reliance, sustained peer-review trust, and strong expert corroboration. Our firm is honored to have supported the client in this approval and looks forward to the client’s continued contributions to organic and medicinal chemistry research in the United States.